Keywords: glaxosmithkline, gets, strong, warning, fda, over, avandia

GlaxoSmithKline gets strong warning from US FDA over Avandia trial reporting

Article | 14 April 2008

Print This

The US Food and Drug Administration has sent a strongly worded letter to UK-based drug giant GlaxoSmithKline's chief executive, Jean-Pierre ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in